Preliminary reports suggest conolidine could inhibit precise ion channels, reducing neuronal excitability and limiting soreness indicators. This system is especially relevant in neuropathic discomfort, wherever irregular signaling causes persistent discomfort. Furthermore, conolidine appears to influence G protein-coupled receptor (GPCR) pathways i